Fractyl Health (GUTS) Return on Sales (2023 - 2025)
Fractyl Health (GUTS) has disclosed Return on Sales for 3 consecutive years, with 32373.67% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Sales fell 3074174.0% year-over-year to 32373.67%, compared with a TTM value of 32373.67% through Sep 2025, down 3157553.0%, and an annual FY2024 reading of 961.13%, down 54800.0% over the prior year.
- Return on Sales was 32373.67% for Q3 2025 at Fractyl Health, down from 5731.76% in the prior quarter.
- Across five years, Return on Sales topped out at 162.79% in Q2 2023 and bottomed at 32373.67% in Q3 2025.
- Average Return on Sales over 3 years is 5022.02%, with a median of 1631.93% recorded in 2024.
- The sharpest move saw Return on Sales surged 171848bps in 2024, then tumbled -3074174bps in 2025.
- Year by year, Return on Sales stood at 1788.29% in 2023, then tumbled by -356bps to 8161.33% in 2024, then crashed by -297bps to 32373.67% in 2025.
- Business Quant data shows Return on Sales for GUTS at 32373.67% in Q3 2025, 5731.76% in Q2 2025, and 1553.28% in Q1 2025.